Atara Biotherapeutics, Inc.

Historical 13F Holders

Symbol
ATRA
CUSIP
046513107
All holders as of
Q4 2023
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2024 Q1 13 1.05 M $715 k
2023 Q4 95 65.3 M $33.5 M
2023 Q3 118 87.6 M $130 M
2023 Q2 125 89.7 M $145 M
2023 Q1 129 101 M $294 M
2022 Q4 144 105 M $344 M
2022 Q3 159 100 M $378 M
2022 Q2 138 99.8 M $777 M
2022 Q1 152 97.9 M $910 M
2021 Q4 144 95.5 M $1.51 B
2021 Q3 143 89.7 M $1.61 B
2021 Q2 148 86.0 M $1.34 B
2021 Q1 153 86.6 M $1.24 B
2020 Q4 161 87.6 M $1.72 B
2020 Q3 149 83.8 M $1.09 B
2020 Q2 131 77.8 M $1.13 B
2020 Q1 120 63.0 M $536 M
2019 Q4 127 62.0 M $1.02 B
2019 Q3 124 59.0 M $833 M
2019 Q2 134 50.5 M $1.01 B
2019 Q1 131 48.9 M $1.94 B
2018 Q4 128 48.8 M $1.69 B
2018 Q3 127 47.1 M $1.95 B
2018 Q2 143 47.0 M $1.73 B
2018 Q1 131 43.9 M $1.71 B
2017 Q4 91 29.9 M $542 M
2017 Q3 86 26.6 M $441 M
2017 Q2 92 25.7 M $360 M
2017 Q1 90 24.1 M $496 M
2016 Q4 89 23.3 M $331 M
2016 Q3 77 22.4 M $479 M
2016 Q2 75 21.8 M $493 M
2016 Q1 73 19.8 M $377 M
2015 Q4 94 19.3 M $510 M
2015 Q3 94 20.1 M $644 M
2015 Q2 77 13.2 M $696 M
2015 Q1 54 11.2 M $462 M
2014 Q4 42 6.76 M $173 M